SEC Form 4 · accession 0001104659-18-056499
Voyager Therapeutics, Inc. · VYGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Pierce
Director
Period of report
Sep 12, 2018
Accepted (ET)
Sep 12, 2018 · 8:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001640266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 12, 2018 | P | 5,000 | $18.44 | A | 5,000 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are directly held by the Pierce Family Trust, dated October 13, 1993 (the "Pierce Family Trust"). The Reporting Person's immediate family members are beneficiaries of the Pierce Family Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.